浙江新省委書記赴杭州考察:阿里(09988.HK)要在國際競爭和造福社會中大顯身手
新上任浙江省委書記易煉紅赴杭州考察時稱,阿里巴巴(09988.HK)要在推動發展和國際競爭方面大顯身手。阿里升2.71%,報88.8元,成交額21.5億。
易煉紅強調,阿里要堅持發展和規範並重,規範資本行為、激發創新活力、增強核心競爭力,在推動發展、國際競爭和造福社會中大顯身手,爭當規範發展模範生、創新發展領頭羊、融通發展服務商支撐者。
中央經濟工作會議上周在北京舉行。會議指,要大力發展數字經濟,提升常態化監管水平,支持平台企業在引領發展、創造就業、國際競爭中大顯身手。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.